Stockhead’s Sarah Hughan sits down with Optiscan’s (ASX:OIL) CEO and managing director Dr Camile Farah to get the short end of the long story on the company’s latest news.

The medical imaging’s business development team has been busy in the US looking to break into an important market segment.

Its non-invasive digital imaging technologies are aimed at bridging the gap between surgery and pathology.

Tune in to hear Optiscan’s Dr Camile Farah on its suite of offerings, more upcoming US event exposure, and more.

 

This video was developed in collaboration with Optiscan, a Stockhead advertiser at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.

Read MoreHealthMedtech

Featured Companies

You might be interested in